Ilse Treurnicht




Ilse Treurnicht is CEO of MaRS (, a large-scale innovation hub in Toronto. MaRS supports entrepreneurs building growth businesses, providing access to critical talent, capital and customer networks. In addition, MaRS works with partners to accelerate adoption and diffusion of innovation in key sectors. Ilse joined MaRS in 2005 from her role as CEO of Primaxis Technology Ventures. She was Chair of the Canadian Task Force on Social Finance (2010), served on the Science, Technology and Innovation Council (STIC) and is a member of the Advisory Council on Economic Growth.  Ilse holds a DPhil in chemistry from Oxford University, which she attended as a Rhodes Scholar.

Latest tweets

  • @IlseTreurnicht
    RT @sickkids: Big thanks to @avarma for your donations and making this giant leap in health care possible 🚀 All insights tonight pointed…
  • @IlseTreurnicht
    RT @sickkids: “We have been living for decades with one sized fit all solutions. To change that we will require a deep understanding of dat…
  • @IlseTreurnicht
    RT @lisamjarvis: FDA expanding cell & gene therapy review group. Agency says by '20, will have >200 cell or gene therapy INDs per year, ad…
  • @IlseTreurnicht
    RT @AsiaPacificFdn: 𝙐𝙋𝘿𝘼𝙏𝙀 | Due to overwhelming demand for #Canada🇨🇦’s first women-only business mission to Asia, we are extending the dea…
iPress s.r.l. | Telefono: +39 0524 57 12 73 | Partita IVA e Codice fiscale: IT02565630346 | email: | website: | PEC: | Cap. Soc. €10.000,00 i.v. | R.E.A. n. PR 248741 | Cookie & Privacy Policy